Pharmaceutical / Drug Definition :
Inhibits calcium transport into myocardial and vascular smooth muscle cells, suppressing contractions. Dilates main coronary arteries and arterioles and inhibits coronary artery spasm, increasing oxygen delivery to heart and decreasing frequency and severity of angina attacks.
In the United States, Nifedipine is regulated by the U.S. Food and Drug Administration (FDA). FDA has specific requirements regarding the registration and listing of Nifedipine.
Registrar Corp assists Nifedipine companies with:
FDA Label Requirements and Exceptions
FDA Import Information
Nifedipine (Nifedipine Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Nifedipine (Nifedipine Suppliers)
- Processors Nifedipine
- Repackers Nifedipine
- Relabelers Nifedipine
- Exporters Nifedipine
- Importers Nifedipine
For more information about Nifedipine, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.